Home›Stock Screener›Gaudium IVF & Women Health

Gaudium IVF & Women Health Share Price Today | Stock Price & Gaudium IVF & Women Health Share Screener

GAUDIUMIVF Healthcare Services
Live Share Price NSE
₹97.40
▼ -4.71 (-4.61%)
2026-11-18 00:00:00
Live Share Price BSE
₹97.55
▼ -4.65 (-4.55%)
2026-11-18 00:00:00

As of November 18, 2026, the live Gaudium IVF & Women Health share price (NSE: GAUDIUMIVF) is ₹97.40 on NSE and ₹97.55 on BSE, down 4.61% from the previous close, with shares trading between ₹96.67 and ₹104.00 in today's trading session, and a 52-week range of ₹70.67–₹125.47. Track Gaudium IVF & Women Health market worth to gauge the company's total market size. Use the Gaudium IVF & Women Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Gaudium IVF & Women Health opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹31 and net income of ₹8, with EBITDA of ₹12, an operating margin of 40.0% and a profit margin of 25.8%.

Gaudium IVF & Women Health Market Cap ₹739.22 Cr.
GAUDIUMIVF P/E Ratio (TTM) 32.10
Gaudium IVF & Women Health P/B Ratio 4.56
EPS (TTM) ₹3.92
Dividend Yield -
Debt to Equity 0.23
GAUDIUMIVF 52 Week High ₹125.47
Gaudium IVF & Women Health 52 Week Low ₹70.67
Operating Margin 40.00%
Profit Margin 25.81%
GAUDIUMIVF Revenue (TTM) ₹31.00
EBITDA ₹12.00
Net Income ₹8.00
Total Assets ₹193.00
Total Equity ₹152.00

Gaudium IVF & Women Health Share Price Chart

Track the current stock price of Gaudium IVF & Women Health with an interactive chart. Analyse GAUDIUMIVF share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Gaudium IVF & Women Health stock quote in one place.

The quote of ₹97.40 sits between the 52-week low of ₹70.67 and the 52-week high of ₹125.47, and the latest session moved -4.61% from the previous close.

Gaudium IVF & Women Health Company Profile - Fundamental Screener

Screen Gaudium IVF & Women Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GAUDIUMIVF shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE0P8B01020.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE0P8B01020

Gaudium IVF & Women Health Balance Sheet Screener

Screen GAUDIUMIVF balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹193, up from ₹89 in 2025.

Latest statistics put total assets at ₹193 and shareholder funds at ₹152, with a leverage ratio of 0.23.

Item 2026 2025 2024 2023 2022

Assets

Total Assets 193 89 57 37 18
Current Assets 0 0 0 0 0
Fixed Assets 18 18 19 18 4

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 2 4 4 4 3
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 152 46 33 23 9
Share Capital 36 31 1 1 1
Reserves & Surplus 116 16 32 22 8

Gaudium IVF & Women Health Income Statement Screener - Profit & Revenue Analysis

Screen Gaudium IVF & Women Health income statement and profit fundamentals. Analyze GAUDIUMIVF quarterly results. Gaudium IVF & Women Health reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹31 and net profit was ₹8, equal to earnings per unit of ₹1.34, at an operating margin of 40%.

In that period expenses were ₹18, interest cost ₹1 and tax ₹2. The next period listed, 2026-Jun, shows revenue of ₹21 and net profit of ₹2.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Dec

Revenue and Expenses

Revenue 31 21 39 27 18 32 25 14
Expenses 18 17 24 18 13 18 18 9

Operating Costs and Margins

EBITDA 12 4 15 9 5 14 7 6
Operating Profit % 40.00% 13.00% 36.00% 32.00% 29.00% 43.00% 27.00% 39.00%
Depreciation 1 1 1 0 1 1 1 1
Interest 1 0 1 0 1 1 1 0

Profit and Earnings

Profit Before Tax 10 3 13 8 4 13 5 5
Tax 2 1 3 2 1 3 1 1
Net Profit 8 2 9 7 3 9 4 3
EPS 1.34 0.25 1.29 1.05 0.50 1.53 0.59 0.55

Gaudium IVF & Women Health Cash Flow Screener - Liquidity Fundamentals

Screen GAUDIUMIVF cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹7, and net cash flow was an inflow of ₹2.

Over the same period, investing activities used ₹88 and financing activities provided ₹82.

Item 2026-March 2025-March 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities 7 9 3 24 -1
Investing Activities -88 -15 -5 -16 -1

Financing and Net Cash

Financing Activities 82 2 -1 5 3
Net Cash Flow 2 -5 -3 14 0

Gaudium IVF & Women Health Shareholding Pattern Screener

See Gaudium IVF & Women Health shareholding pattern with promoter, FII, and DII holdings. Check Gaudium IVF & Women Health promoter holding and ownership changes for GAUDIUMIVF on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Feb, promoters held 71.29%, foreign institutions 9.24%, domestic institutions 5.11% and the public 13.52%, spread across 7 shareholders.

The shareholder count was 7 in 2026-Feb, compared with 19,854 in 2026-Mar.

Item 2026-Feb 2026-Mar 2026-Jun 2026-Sept 2025-Jan 2025-Sept

Promoter Holding

Promoter Holding 71.29% 71.29% 71.29% 71.29% 99.98% 99.98%

Institutional Investors

FII Holding 9.24% 6.70% 3.02% 1.19% 0.00% 0.00%
DII Holding 5.11% 2.62% 2.22% 2.22% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 13.52% 14.67% 16.78% 18.19% 0.00% 0.00%
Other Holding 0.84% 4.73% 6.69% 7.10% 0.02% 0.02%
Shareholder Count 7 19,854 21,910 24,051 7 7

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Gaudium IVF & Women Health. Gaudium IVF & Women Health dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Gaudium IVF & Women Health.

Gaudium IVF & Women Health Stock Index Membership - Nifty & Sensex

See which indices include Gaudium IVF & Women Health stock. Check GAUDIUMIVF index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Gaudium IVF & Women Health is not part of any tracked indices.
Only major market indices are tracked in our system.

Gaudium IVF & Women Health Market Events Screener - Corporate Actions

Get Gaudium IVF & Women Health corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Gaudium IVF & Women Health stock events that may affect GAUDIUMIVF share price, along with derivatives, futures and options activity and sector gainers.

5 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 12, 2026, with a record date of November 12, 2026.

It is followed by Annual General Meeting dated September 28, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-12 2026-11-12 Quarterly Result Announcement NA 4.50%
2026-09-28 2026-09-28 Annual General Meeting NA -6.40%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -6.91%
2026-05-28 2026-05-28 Quarterly Result Announcement NA 0.04%
2026-03-18 2026-03-18 Quarterly Result Announcement NA 5.06%

Gaudium IVF & Women Health Competitors Screener - Peer Stocks Comparison

Screen GAUDIUMIVF competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 127,213 53.50 25,420 15.58% 2,003 61.89
Max Healthcare Institute 100,981 72.60 8,536 18.82% 1,442 76.17
Manipal Health Enterprises 91,984 105.70 10,521 25.80% 917 60.80
Aster DM Quality Care 65,009 114.20 4,769 11.25% 427 57.55
Fortis Healthcare 60,936 57.30 9,179 16.93% 1,064 57.30
Global Health 39,228 63.30 4,509 19.56% 554 64.64
Narayana Hrudayalaya 39,012 45.30 7,996 43.43% 811 61.49
Dr. Lal Path Labs 33,266 56.50 2,864 12.11% 510 54.28
Krishna Institute of Medical Sciences 32,191 163.70 3,931 28.16% 242 66.73
Syngene International 17,584 94.20 3,809 2.56% 317 61.78

Gaudium IVF & Women Health Company Announcements - News & Reports Screener

Screen GAUDIUMIVF latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated November 18, 2026 and November 18, 2026.

Date Update Actions
Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-18 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-18 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-11-17 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-15 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-14 Rectification Of Inadvertent Typographical Error In The Unaudited Consolidated Financial Results Submitted As Part Of The Outcome Of The Board Meeting Held On November 12 2026 -
2026-11-14 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-11-14 Revised Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information Pursuant To Regulation 8(2) Of SEBI (PIT) Regulations 2015. -
2026-11-14 Statement Of Deviation(S) Or Variation(S) Under Regulation 32 -
2026-11-14 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-14 Announcement under Regulation 30 (LODR)-Change in Management -
2026-11-14 Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2026 -
2026-11-14 Board Meeting Outcome for For Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2026 -
2026-11-13 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-06 Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30 2026 -
2026-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-28 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-25 Closure of Trading Window -
2026-09-24 Intimation Under Regulation 30 And Para B Schedule III - Commencement Of Commercial Operations Of New IVF Centre/Hub At Gurgaon Haryana -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹97.40, within a 52-week range of ₹70.67 to ₹125.47. The P/E ratio is 32.10 and the P/B ratio is 4.56, with earnings per unit of ₹3.92. Market capitalisation stands at ₹739.22 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 5 balance sheet periods, 8 income statement periods, 5 cash flow years and 6 shareholding periods. Information is provided for research and is not investment advice.